Formamide → HCID 71584842, compound
Reaction equation
Cl[C:2]1[CH:11]=[C:10]2[C:5]([CH:6]=[C:7]([C:15]3[C:16]([CH3:41])=[CH:17][C:18]([F:40])=[C:19]([NH:21][C:22]([NH:24][C:25]4[CH:30]=[CH:29][C:28]([F:31])=[C:27]([CH2:32][N:33]5[CH2:38][CH2:37][N:36]([CH3:39])[CH2:35][CH2:34]5)[CH:26]=4)=[O:23])[CH:20]=3)[C:8](=[O:14])[N:9]2[CH2:12][CH3:13])=[CH:4][N:3]=1.[CH:42]([NH2:44])=[O:43].C([O-])([O-])=O.[K+].[K+]>O1CCOCC1.CC(C1C=C(C(C)C)C(C2C(P(C3CCCCC3)C3CCCCC3)=C(OC)C=CC=2OC)=C(C(C)C)C=1)C.C1C=[C-]C(CCN)=CC=1.Cl[Pd+]>[CH2:12]([N:9]1[C:10]2[C:5](=[CH:4][N:3]=[C:2]([NH:44][CH:42]=[O:43])[CH:11]=2)[CH:6]=[C:7]([C:15]2[CH:20]=[C:19]([NH:21][C:22]([NH:24][C:25]3[CH:30]=[CH:29][C:28]([F:31])=[C:27]([CH2:32][N:33]4[CH2:38][CH2:37][N:36]([CH3:39])[CH2:35][CH2:34]4)[CH:26]=3)=[O:23])[C:18]([F:40])=[CH:17][C:16]=2[CH3:41])[C:8]1=[O:14])[CH3:13]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 100 °C
Procedure
A mixture of 1-(5-(7-chloro-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoro-4-methylphenyl)-3-(4-fluoro-3-((4-methylpiperazin-1-yl)methyl)phenyl)urea (0.120 g, 0.207 mmol), formamide (0.041 ml, 1.033 mmol) and K2CO3 (0.057 g, 0.413 mmol) in dioxane (3 mL) was sparged with Ar, treated with BrettPhos Palladacycle (8.05 mg, 10.33 μmol), sparged again with Ar, and heated to 100° C. for 1 h. The mixture was cooled to RT, treated with EtOAc and satd. NaHCO3, filtered to remove insoluble material and the layers separated. The organic layer was washed with brine, dried over MgSO4 and concentrated to dryness. The material was treated with a small amount of DCM, allowed to stand at RT, and the resulting solid collected via filtration and dried. The filtrate was concentrated to dryness, layered with a small amount of DCM and allowed to stand at RT overnight. The resulting solid was collected via filtration and combined with the above-isolated solid to afford N-(1-ethyl-3-(4-fluoro-5-(3-(4-fluoro-3-((4-methylpiperazin-1-yl)methyl)phenyl)ureido)-2-methylphenyl)-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)formamide (53 mg, 44% yield). 1H NMR (400 MHz, DMSO-d6): δ 9.38 (m, 1H), 9.05 (s, 1H), 8.69 (d, J=18.4 Hz, 1H), 8.44 (s, 1H), 8.21 (s, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.90 (s, 1H), 7.43 (dd, J=6.5, 2.8 Hz, 1H), 7.30 (ddd, J=8.9, 4.4, 2.8 Hz, 1H), 7.16 (d, J=12.2 Hz, 1H), 7.05 (t, J=9.3 Hz, 1H), 6.96 (s, 1H), 4.19 (m, 2H), 3.42 (s, 2H), 2.41-2.19 (m, 8H), 2.10 (s, 3H), 2.07 (s, 3H), 1.24 (m, 3H); MS (ESI) m/z: 590.2 [M+H]+.
Workup
- customwas sparged with Ar
- customsparged again with Ar
- temperatureThe mixture was cooled to RT
- additiontreated with EtOAc
- filtrationNaHCO3, filtered
- customto remove insoluble material
- customthe layers separated
- washThe organic layer was washed with brine
- dry with materialdried over MgSO4
- concentrationconcentrated to dryness
- additionThe material was treated with a small amount of DCM
- customto stand at RT
- filtrationthe resulting solid collected via filtration
- customdried
- concentrationThe filtrate was concentrated to dryness
- filtrationThe resulting solid was collected via filtration
Sources & evidence
- ORD record
- ord-dbb96143807449998a8657d82bc53ca4
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08461179B1
Reaction notes
Loading…